Test |
Estradiol – E2 |
Test Code |
510 |
Specimen |
serum |
Unit |
pmol/L |
Station |
Chemistry |
Synonym Name/Abbreviation |
AFP |
CPT Code |
82670 |
Performing Facility |
American Medical Labs, Herzliya |
Analyzer |
Roche cobas 6000 |
Test Method |
Electrochemiluminescence immunoassay (ECLIA) |
AML Preferred Tube |
5 mL SST gel |
Storage Instructions |
Refrigerated.
Stability: 12 hours 25oC Freeze only once.
|
Min. Volume |
1 mL |
Turn-Around-Time |
One day. |
Intended Use |
Immunoassay for the in vitro quantitative determination of estradiol in human serum and plasma. Estrogens are produced primarily in the ovary (follicle, corpus luteum), but small quantities are also formed in the testes and in the adrenal cortex.During pregnancy, estrogens are mainly formed in the placenta. About 98 % of estradiol is bound to transport proteins (SHBG = sex hormone binding globulin). Estrogen secretion is biphasic during the menstrual cycle. The determination of estradiol is utilized clinically in the elucidation of fertility disorders in the hypothalamus‑pituitary‑gonad axis, gynecomastia, estrogen‑producing ovarian and testicular tumors and in hyperplasia of the adrenal cortex. Further clinical indications are the monitoring of fertility therapy and determining the time of ovulation within the framework of in vitro fertilization (IVF). |
Limitations |
Samples should not be taken from patients receiving therapy with high biotin doses (i.e. > 5 mg/day) until at least 8 hours following the last biotin administration. 18.4-11010 pmol/L |
Patient Preparation |
No patient preparation. |
Reasons for Rejection |
Improper labelling. |
Adult Reference Ranges |
Man: 99.4 to 192 pmol/L
Woman: Follicular=98.1 to 571 Ovulation=176.5 to 1153 Luteal= 122 to 1094 Postmenopausal= less than 18.4 to 183 |